Stay updated on SPL7013 Gel in BV Recurrence Prevention Clinical Trial
Sign up to get notified when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.

Latest updates to the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page
- Check6 days agoChange DetectedFooter now shows Revision: v3.3.3; the HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedThe site revision has been updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedRemoved the government funding/operating-status notice from the page.SummaryDifference0.2%

- Check56 days agoChange DetectedNo significant changes detected between versions; the page content and study results appear unchanged.SummaryDifference0.0%

- Check84 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference2%

- Check92 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.1%

Stay in the know with updates to SPL7013 Gel in BV Recurrence Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.